A successful Medical Affairs launch strategy requires every part of an organization to work in sync. For Medical Affairs, it means that by the time a product “hits” the market, most of the function will be staffed. It also means the medical field team programs will have gradually matured into a fully operational structure. Thought [...]
The Altered Pharmaceutical Thought Leader Pool: How the Implementation of the Sunshine Act and CMS Open Payment Program Changed the KOL Landscape Since the adoption of the Sunshine Act in 2010 and the subsequent thought leaders’ payments reporting on the CMS Open Payment Program in 2014, many things have changed for pharmaceutical companies. It took [...]
There’s a category of thought leader that has long been overlooked, but the data now suggests companies can no longer afford to do so—that category is the Non-MD category of Nurse Practitioners (NP) and Physician Assistants (PA). From our contacts in continuing medical education (CME), we’ve heard there has been a marked increase in the [...]
The development of a drug or medical device – the product’s life cycle – is a lengthy process that involves research, clinical trials, and input from professional peers. Pharmaceutical companies and health care suppliers spend months, and even years, as well as millions of dollars before putting a life-changing product on the market. The Medical [...]
MSL positions were created in the late 60’s to inform and influence Key Opinion Leaders (KOLs) in the medical field through relationships and research collaborations. Over time, the role of the MSL has evolved and now almost all MSLs serve as vital resources for pharmaceutical and biotech firms in regards to staying on top of [...]
This infographic depicts the essence of the (Medical Science Liaison) MSL universe. The data provided in this graphic are based on our extensive research on the Medical Affairs function, the Medical Science Liaison salary and activities, and KOL feedback studies. These metrics outline the general (average) profile of a typical MSL. Individual MSL roles will [...]
Are you wondering how to become a Medical Science Liaison (MSL)? A MSL connects life science organizations to industry thought leaders (or KOLs) by sharing scientific and clinical information on products and involving these KOLs in research, speaking or consulting activities. Here’s what you can expect from your journey of medical science liaison training and [...]
Pharmaceutical companies wouldn’t be able to do what they do well without the help of the role of Medical Science Liaisons, most commonly called MSLs. The role of Medical Science Liaisons is to provide the expertise to disseminate scientific and clinical information to the medical community, which in turns enables innovation in drug development and [...]
Recent research shows KOL lifecycle involvement. There are a significant number of surveyed organizations – 39%, as shown in the figure below – reported that initial engagements with thought leaders start during phase 3 of a product’s lifecycle. Two percent begin at launch, but starting to cultivate thought leader relationships so late in a product [...]
Research shows what European KOLs think of MSLs they interact with. Through the deployment of scientific field teams (MSLs), organizations’ intentions are to share medical and clinical knowledge of products with the thought leaders who in turn can spread the information to physician communities and ultimately enhance patient experiences. In the process, thought leaders become [...]
